Related content

The efficacy of carmustine wafers for older patients with glioblastoma multiforme: prolonging survival

By Chaichana Kaisorn L   Zaidi Hasan   Pendleton Courtney   McGirt Matthew J   Grossman Rachel   Weingart Jon D   Olivi Alessandro   Quiñones-Hinojosa Alfredo   Brem Henry  

Neurological Research, Vol. 33, Iss. 7, 2011-09 ,pp. : 759-764

Maney Publishing

Access to resources Recommend Favorite

Long-term survival with glioblastoma multiforme

By Krex Dietmar  

Brain, Vol. 130, Iss. 10, 2007-10 ,pp. : 2596-2606

Oxford University Press

Access to resources Recommend Favorite

What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by ¹⁹²Ir brachytherapy?

By Koot R. W.   Habraken J. B. A.   Hulshof M. C. C. M.   Paans A. M. J.   Bosch D. A.   Pruim J.  

Acta Neurochirurgica, Vol. 150, Iss. 4, 2008-04 ,pp. : 345-349

Springer Publishing Company

Access to resources Recommend Favorite

The importance of genomic copy number changes in the prognosis of glioblastoma multiforme

By Arslantas Ali   Artan Sevilhan   Öner Ülkü   Müslümanoğlu Hamza   Durmaz Ramazan   Cosan Erhan   Atasoy Metin   Başaran Nurettin   Tel Eşref  

Neurosurgical Review, Vol. 27, Iss. 1, 2004-01 ,pp. : 58-64

Springer Publishing Company

Access to resources Recommend Favorite

Relationship between expression of O⁶-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

By Anda Takeo   Shabani Hamisi Kimaro   Tsunoda Keishi   Tokunaga Yoshiharu   Kaminogo Makio   Shibata Shobu   Hayashi Tomayoshi   Iseki Masachika  

Neurological Research, Vol. 25, Iss. 3, 2003-04 ,pp. : 241-248

Maney Publishing

Access to resources Recommend Favorite